 | • レポートコード：GIR-2104Z03159 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、慢性肺疾患治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。慢性肺疾患治療の種類別市場規模（注射、カプセル、錠剤、その他）、用途別市場規模（気管支肺異形成症、喘息、COPD、肺線維症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・慢性肺疾患治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Boehringer Ingelheim、Novartis、Roche、Astellas Pharma、Dr. Reddy’s Laboratories、GlaxoSmithKline、AstraZeneca、Sanofi、Teva Pharmaceuticals、Asmacure Ltée ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射、カプセル、錠剤、その他 ・用途別分析2016年-2026年：気管支肺異形成症、喘息、COPD、肺線維症 ・慢性肺疾患治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・慢性肺疾患治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・慢性肺疾患治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・慢性肺疾患治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・慢性肺疾患治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chronic Lung Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Chronic Lung Diseases Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Chronic Lung Diseases Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Chronic Lung Diseases Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Capsule
Tablet
Other
Market segment by Application, can be divided into
Bronchopulmonary Dysplasia
Asthma
COPD
Pulmonary Fibrosis
Market segment by players, this report covers
Boehringer Ingelheim
Novartis
Roche
Astellas Pharma
Dr. Reddy’s Laboratories
GlaxoSmithKline
AstraZeneca
Sanofi
Teva Pharmaceuticals
Asmacure Ltée
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Chronic Lung Diseases Treatment
1.2 Classification of Chronic Lung Diseases Treatment by Type
1.2.1 Overview: Global Chronic Lung Diseases Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Chronic Lung Diseases Treatment Revenue Market Share by Type in 2020
1.2.3 Injection
1.2.4 Capsule
1.2.5 Tablet
1.2.6 Other
1.3 Global Chronic Lung Diseases Treatment Market by Application
1.3.1 Overview: Global Chronic Lung Diseases Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Bronchopulmonary Dysplasia
1.3.3 Asthma
1.3.4 COPD
1.3.5 Pulmonary Fibrosis
1.4 Global Chronic Lung Diseases Treatment Market Size & Forecast
1.5 Global Chronic Lung Diseases Treatment Market Size and Forecast by Region
1.5.1 Global Chronic Lung Diseases Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Chronic Lung Diseases Treatment Market Size by Region, (2016-2021)
1.5.3 North America Chronic Lung Diseases Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Chronic Lung Diseases Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Chronic Lung Diseases Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Chronic Lung Diseases Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Chronic Lung Diseases Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Chronic Lung Diseases Treatment Market Drivers
1.6.2 Chronic Lung Diseases Treatment Market Restraints
1.6.3 Chronic Lung Diseases Treatment Trends Analysis
2 Company Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Chronic Lung Diseases Treatment Product and Solutions
2.1.4 Boehringer Ingelheim Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Chronic Lung Diseases Treatment Product and Solutions
2.2.4 Novartis Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Chronic Lung Diseases Treatment Product and Solutions
2.3.4 Roche Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Roche Recent Developments and Future Plans
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business
2.4.3 Astellas Pharma Chronic Lung Diseases Treatment Product and Solutions
2.4.4 Astellas Pharma Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Astellas Pharma Recent Developments and Future Plans
2.5 Dr. Reddy’s Laboratories
2.5.1 Dr. Reddy’s Laboratories Details
2.5.2 Dr. Reddy’s Laboratories Major Business
2.5.3 Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Product and Solutions
2.5.4 Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Dr. Reddy’s Laboratories Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Chronic Lung Diseases Treatment Product and Solutions
2.6.4 GlaxoSmithKline Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Chronic Lung Diseases Treatment Product and Solutions
2.7.4 AstraZeneca Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 AstraZeneca Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Chronic Lung Diseases Treatment Product and Solutions
2.8.4 Sanofi Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Teva Pharmaceuticals
2.9.1 Teva Pharmaceuticals Details
2.9.2 Teva Pharmaceuticals Major Business
2.9.3 Teva Pharmaceuticals Chronic Lung Diseases Treatment Product and Solutions
2.9.4 Teva Pharmaceuticals Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.10 Asmacure Ltée
2.10.1 Asmacure Ltée Details
2.10.2 Asmacure Ltée Major Business
2.10.3 Asmacure Ltée Chronic Lung Diseases Treatment Product and Solutions
2.10.4 Asmacure Ltée Chronic Lung Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Asmacure Ltée Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Chronic Lung Diseases Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Lung Diseases Treatment Players Market Share
3.2.2 Top 10 Chronic Lung Diseases Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Chronic Lung Diseases Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Chronic Lung Diseases Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Chronic Lung Diseases Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Chronic Lung Diseases Treatment Revenue Market Share by Application (2016-2021)
5.2 Chronic Lung Diseases Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Chronic Lung Diseases Treatment Revenue by Type (2016-2026)
6.2 North America Chronic Lung Diseases Treatment Revenue by Application (2016-2026)
6.3 North America Chronic Lung Diseases Treatment Market Size by Country
6.3.1 North America Chronic Lung Diseases Treatment Revenue by Country (2016-2026)
6.3.2 United States Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Chronic Lung Diseases Treatment Revenue by Type (2016-2026)
7.2 Europe Chronic Lung Diseases Treatment Revenue by Application (2016-2026)
7.3 Europe Chronic Lung Diseases Treatment Market Size by Country
7.3.1 Europe Chronic Lung Diseases Treatment Revenue by Country (2016-2026)
7.3.2 Germany Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
7.3.3 France Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Chronic Lung Diseases Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Chronic Lung Diseases Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region
8.3.1 Asia-Pacific Chronic Lung Diseases Treatment Revenue by Region (2016-2026)
8.3.2 China Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
8.3.5 India Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Chronic Lung Diseases Treatment Revenue by Type (2016-2026)
9.2 South America Chronic Lung Diseases Treatment Revenue by Application (2016-2026)
9.3 South America Chronic Lung Diseases Treatment Market Size by Country
9.3.1 South America Chronic Lung Diseases Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Chronic Lung Diseases Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Chronic Lung Diseases Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country
10.3.1 Middle East & Africa Chronic Lung Diseases Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Chronic Lung Diseases Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Chronic Lung Diseases Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Chronic Lung Diseases Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Chronic Lung Diseases Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Chronic Lung Diseases Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Chronic Lung Diseases Treatment Revenue Market Share by Region (2021-2026)
Table 6. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 7. Boehringer Ingelheim Major Business
Table 8. Boehringer Ingelheim Chronic Lung Diseases Treatment Product and Solutions
Table 9. Boehringer Ingelheim Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Chronic Lung Diseases Treatment Product and Solutions
Table 13. Novartis Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Roche Corporate Information, Head Office, and Major Competitors
Table 15. Roche Major Business
Table 16. Roche Chronic Lung Diseases Treatment Product and Solutions
Table 17. Roche Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Astellas Pharma Major Business
Table 20. Astellas Pharma Chronic Lung Diseases Treatment Product and Solutions
Table 21. Astellas Pharma Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Dr. Reddy’s Laboratories Corporate Information, Head Office, and Major Competitors
Table 23. Dr. Reddy’s Laboratories Major Business
Table 24. Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Product and Solutions
Table 25. Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 27. GlaxoSmithKline Major Business
Table 28. GlaxoSmithKline Chronic Lung Diseases Treatment Product and Solutions
Table 29. GlaxoSmithKline Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Chronic Lung Diseases Treatment Product and Solutions
Table 33. AstraZeneca Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi Chronic Lung Diseases Treatment Product and Solutions
Table 37. Sanofi Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Teva Pharmaceuticals Major Business
Table 40. Teva Pharmaceuticals Chronic Lung Diseases Treatment Product and Solutions
Table 41. Teva Pharmaceuticals Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Asmacure Ltée Corporate Information, Head Office, and Major Competitors
Table 43. Asmacure Ltée Major Business
Table 44. Asmacure Ltée Chronic Lung Diseases Treatment Product and Solutions
Table 45. Asmacure Ltée Chronic Lung Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Chronic Lung Diseases Treatment Revenue (USD Million) by Players (2019-2021)
Table 47. Global Chronic Lung Diseases Treatment Revenue Share by Players (2019-2021)
Table 48. Breakdown of Chronic Lung Diseases Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Chronic Lung Diseases Treatment Players Head Office, Products and Services Provided
Table 50. Chronic Lung Diseases Treatment Mergers & Acquisitions in the Past Five Years
Table 51. Chronic Lung Diseases Treatment New Entrants and Expansion Plans
Table 52. Global Chronic Lung Diseases Treatment Revenue (USD Million) by Type (2016-2021)
Table 53. Global Chronic Lung Diseases Treatment Revenue Share by Type (2016-2021)
Table 54. Global Chronic Lung Diseases Treatment Revenue Forecast by Type (2021-2026)
Table 55. Global Chronic Lung Diseases Treatment Revenue by Application (2016-2021)
Table 56. Global Chronic Lung Diseases Treatment Revenue Forecast by Application (2021-2026)
Table 57. North America Chronic Lung Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Chronic Lung Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Chronic Lung Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Chronic Lung Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Chronic Lung Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Chronic Lung Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Chronic Lung Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Chronic Lung Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Chronic Lung Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Chronic Lung Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Chronic Lung Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Chronic Lung Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Chronic Lung Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Chronic Lung Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Chronic Lung Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Chronic Lung Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Chronic Lung Diseases Treatment Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Chronic Lung Diseases Treatment Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Chronic Lung Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Chronic Lung Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Chronic Lung Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Chronic Lung Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Chronic Lung Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Chronic Lung Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Chronic Lung Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Chronic Lung Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Chronic Lung Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Chronic Lung Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Chronic Lung Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Chronic Lung Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Chronic Lung Diseases Treatment Picture
Figure 2. Global Chronic Lung Diseases Treatment Revenue Market Share by Type in 2020
Figure 3. Injection
Figure 4. Capsule
Figure 5. Tablet
Figure 6. Other
Figure 7. Chronic Lung Diseases Treatment Revenue Market Share by Application in 2020
Figure 8. Bronchopulmonary Dysplasia Picture
Figure 9. Asthma Picture
Figure 10. COPD Picture
Figure 11. Pulmonary Fibrosis Picture
Figure 12. Global Chronic Lung Diseases Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Chronic Lung Diseases Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Chronic Lung Diseases Treatment Revenue Market Share by Region (2016-2026)
Figure 15. Global Chronic Lung Diseases Treatment Revenue Market Share by Region in 2020
Figure 16. North America Chronic Lung Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Chronic Lung Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Chronic Lung Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Chronic Lung Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Chronic Lung Diseases Treatment Market Drivers
Figure 21. Chronic Lung Diseases Treatment Market Restraints
Figure 22. Chronic Lung Diseases Treatment Market Trends
Figure 23. Boehringer Ingelheim Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Astellas Pharma Recent Developments and Future Plans
Figure 27. Dr. Reddy’s Laboratories Recent Developments and Future Plans
Figure 28. GlaxoSmithKline Recent Developments and Future Plans
Figure 29. AstraZeneca Recent Developments and Future Plans
Figure 30. Sanofi Recent Developments and Future Plans
Figure 31. Teva Pharmaceuticals Recent Developments and Future Plans
Figure 32. Asmacure Ltée Recent Developments and Future Plans
Figure 34. Global Chronic Lung Diseases Treatment Revenue Share by Players in 2020
Figure 35. Chronic Lung Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Chronic Lung Diseases Treatment Revenue Market Share in 2020
Figure 37. Global Top 10 Players Chronic Lung Diseases Treatment Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Chronic Lung Diseases Treatment Revenue Share by Type in 2020
Figure 40. Global Chronic Lung Diseases Treatment Market Share Forecast by Type (2021-2026)
Figure 41. Global Chronic Lung Diseases Treatment Revenue Share by Application in 2020
Figure 42. Global Chronic Lung Diseases Treatment Market Share Forecast by Application (2021-2026)
Figure 43. North America Chronic Lung Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 44. North America Chronic Lung Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 45. North America Chronic Lung Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 46. United States Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Chronic Lung Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 50. Europe Chronic Lung Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 51. Europe Chronic Lung Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 52. Germany Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Chronic Lung Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Chronic Lung Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Chronic Lung Diseases Treatment Revenue Market Share by Region (2016-2026)
Figure 60. China Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Chronic Lung Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 67. South America Chronic Lung Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 68. South America Chronic Lung Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Chronic Lung Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Chronic Lung Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Chronic Lung Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Chronic Lung Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の慢性肺疾患治療市場規模・現状・予測（2021年-2027年） Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…- 世界の孤児肺疾患治療市場規模・現状・予測（2021年-2027年） Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are e…
- 世界の慢性閉塞性肺疾患（COPD）治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema characterized by airflow obstruction, which can further develop into a common chronic disease of cor pulmona and respiratory failure.It is related to the abnormal inflammatory reaction of harmful gases and harmful …
- 世界の慢性疾患管理市場規模・現状・予測（2021年-2027年） Chronic Disease Management which was also known as enhanced primary care earlier is the ongoing care and support which help in managing the health care of patient suffering with chronic disease such as asthma, cancer, diabetes, cardiovascular diseases, stroke, etc. It also require visits and support…
- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…